San Diego, CA, United States of America

Decipher Biosciences, Inc.


USPTO Granted Patents = 7


Trademarks = 5

Forward Citations = 24

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Elai Davicioni (7 out of 15 patents)

silverMedal Nicholas Erho (6 out of 7 patents)

bronzeMedal Hussam Al-Deen Ashab (3 out of 3 patents)

4.  Shuang Zhao (2 out of 5 patents)

5.  Ismael A Vergara Correa (2 out of 3 patents)

6.  Felix Y Feng (2 out of 3 patents)

7.  Sei-Won Laura Chang (1 out of 1 patent)

8.  Peter Black (1 out of 1 patent)

9.  Mohammed Alshalalfa (1 out of 1 patent)

10.  Christine Buerki (1 out of 2 patents)

11.  Anamaria Crisan (1 out of 2 patents)

12.  Mercedeh Ghadessi (1 out of 2 patents)

13.  Robert B Jenkins (1 out of 18 patents)

14.  S Laura Chang (1 out of 1 patent)

15.  Nicholas George Erho (2 patents)


7 patents:

Company Overview
Decipher Biosciences is a precision oncology company focused on developing and delivering advanced cancer diagnostics that provide actionable information to healthcare providers and patients. The company's innovative technology platform integrates genomic data with clinical information to guide personalized treatment decisions for cancer patients.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#702 in San Diego, CA

#9,491 in California

#39,879 in US

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 24

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Decipher Biosciences, Inc.. Retrieved from https://idiyas.com/company/decipher-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…